Brief: Pharmaust Raises A$3.5 Million At A Premium
13/12/2023 24:52
Dec 13 (Reuters) - Pharmaust Ltd PAA.AX :
* RAISES A$3.5 MILLION AT A PREMIUM
* PLACEMENT AT OFFER PRICE OF 10 AU CENTS PER NEW SHARE
Source text for Eikon: ID:nASX99GV71
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility